{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:37:39Z","timestamp":1789612659706,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/50917-0"],"award-info":[{"award-number":["2014\/50917-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00787-024-02622-4","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:07:08Z","timestamp":1733184428000},"page":"2107-2117","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Enhanced neurobiological biomarker differentiation for attention-deficit\/hyperactivity disorder through a risk-informed design"],"prefix":"10.1007","volume":"34","author":[{"given":"Igor","family":"Duarte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio Scopel","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni A.","family":"Salum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas Teixeira","family":"Leffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sintia","family":"Belangero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Kiyomi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Toshio","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro M.","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis C.","family":"Farhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aja Louise","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euripedes C.","family":"Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kieling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Augusto","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Caye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"key":"2622_CR1","doi-asserted-by":"publisher","unstructured":"Abi-Dargham A et al (2023) Jun., Candidate biomarkers in psychiatric disorders: state of the field, World Psychiatry, vol. 22, no. 2, pp. 236\u2013262, https:\/\/doi.org\/10.1002\/wps.21078","DOI":"10.1002\/wps.21078"},{"key":"2622_CR2","doi-asserted-by":"publisher","unstructured":"Garcia-Gutierrez MS, Manzanares J, Navarrete F (Jul. 2021) Editorial: the search for biomarkers in Psychiatry. Front Psychiatry 12:720411. https:\/\/doi.org\/10.3389\/fpsyt.2021.720411","DOI":"10.3389\/fpsyt.2021.720411"},{"key":"2622_CR3","doi-asserted-by":"publisher","unstructured":"Faraone SV et al (2021) Sep., The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder, Neurosci. Biobehav. Rev., vol. 128, pp. 789\u2013818, https:\/\/doi.org\/10.1016\/j.neubiorev.2021.01.022","DOI":"10.1016\/j.neubiorev.2021.01.022"},{"key":"2622_CR4","doi-asserted-by":"publisher","unstructured":"Faraone SV et al (Aug. 2015) Attention-deficit\/hyperactivity disorder. Nat Rev Dis Primer 1:15020. https:\/\/doi.org\/10.1038\/nrdp.2015.20","DOI":"10.1038\/nrdp.2015.20"},{"key":"2622_CR5","doi-asserted-by":"crossref","unstructured":"Posner J, Polanczyk GV, Sonuga-Barke E (2020) Attention-deficit hyperactivity disorder, Lancet Lond. Engl., vol. 395, no. 10222, Art. no. 10222, Feb. https:\/\/doi.org\/10.1016\/S0140-6736(19)33004-1","DOI":"10.1016\/S0140-6736(19)33004-1"},{"key":"2622_CR6","doi-asserted-by":"publisher","unstructured":"Faraone SV et al (Feb. 2024) Attention-deficit\/hyperactivity disorder. Nat Rev Dis Primer 10(1). https:\/\/doi.org\/10.1038\/s41572-024-00495-0","DOI":"10.1038\/s41572-024-00495-0"},{"key":"2622_CR7","doi-asserted-by":"publisher","unstructured":"Hoogman M et al (Apr. 2017) Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis. Lancet Psychiatry 4(4):310\u2013319. https:\/\/doi.org\/10.1016\/S2215-0366(17)30049-4","DOI":"10.1016\/S2215-0366(17)30049-4"},{"key":"2622_CR8","doi-asserted-by":"publisher","unstructured":"Cortese S et al (2023) Feb., Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review, World Psychiatry, vol. 22, no. 1, pp. 129\u2013149, https:\/\/doi.org\/10.1002\/wps.21037","DOI":"10.1002\/wps.21037"},{"key":"2622_CR9","doi-asserted-by":"publisher","unstructured":"Demontis D et al (Feb. 2023) Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains. Nat Genet 55(2):198\u2013208. https:\/\/doi.org\/10.1038\/s41588-022-01285-8","DOI":"10.1038\/s41588-022-01285-8"},{"key":"2622_CR10","doi-asserted-by":"publisher","unstructured":"Hoogman M et al (Jan. 2022) Consortium neuroscience of attention deficit\/hyperactivity disorder and autism spectrum disorder: the ENIGMA adventure. Hum Brain Mapp 43(1):37\u201355. https:\/\/doi.org\/10.1002\/hbm.25029","DOI":"10.1002\/hbm.25029"},{"key":"2622_CR11","doi-asserted-by":"publisher","unstructured":"Pievsky MA, McGrath RE (Mar. 2018) The Neurocognitive Profile of Attention-Deficit\/Hyperactivity disorder: a review of Meta-analyses. Arch Clin Neuropsychol 33(2):143\u2013157. https:\/\/doi.org\/10.1093\/arclin\/acx055","DOI":"10.1093\/arclin\/acx055"},{"key":"2622_CR12","doi-asserted-by":"publisher","unstructured":"Tamm L, Loren REA, Peugh J, Ciesielski HA (2021) The Association of Executive Functioning With Academic, Behavior, and Social Performance Ratings in Children With ADHD, J Learn Disabil, vol. 54, no. 2, pp. 124\u2013138, Mar. https:\/\/doi.org\/10.1177\/0022219420961338","DOI":"10.1177\/0022219420961338"},{"key":"2622_CR13","doi-asserted-by":"publisher","unstructured":"Coghill D, Sonuga-Barke EJS (May 2012) Annual Research Review: categories versus dimensions in the classification and conceptualisation of child and adolescent mental disorders\u2013 implications of recent empirical study. J Child Psychol Psychiatry 53(5):469\u2013489. https:\/\/doi.org\/10.1111\/j.1469-7610.2011.02511.x","DOI":"10.1111\/j.1469-7610.2011.02511.x"},{"key":"2622_CR14","doi-asserted-by":"publisher","unstructured":"Luo Y, Weibman D, Halperin JM, Li X (Feb. 2019) A review of heterogeneity in attention Deficit\/Hyperactivity disorder (ADHD). Front Hum Neurosci 13:42. https:\/\/doi.org\/10.3389\/fnhum.2019.00042","DOI":"10.3389\/fnhum.2019.00042"},{"key":"2622_CR15","doi-asserted-by":"publisher","unstructured":"Sibley MH et al (Feb. 2022) Variable patterns of Remission from ADHD in the Multimodal treatment study of ADHD. Am J Psychiatry 179(2):142\u2013151. https:\/\/doi.org\/10.1176\/appi.ajp.2021.21010032","DOI":"10.1176\/appi.ajp.2021.21010032"},{"key":"2622_CR16","doi-asserted-by":"publisher","unstructured":"Caye A et al (Dec. 2016) Life span studies of ADHD\u2014Conceptual challenges and predictors of Persistence and Outcome. Curr Psychiatry Rep 18(12):111. https:\/\/doi.org\/10.1007\/s11920-016-0750-x","DOI":"10.1007\/s11920-016-0750-x"},{"key":"2622_CR17","doi-asserted-by":"publisher","unstructured":"Caye A et al (May 2019) A risk calculator to predict adult attention-deficit\/hyperactivity disorder: generation and external validation in three birth cohorts and one clinical sample. Epidemiol Psychiatr Sci 29:e37. https:\/\/doi.org\/10.1017\/S2045796019000283","DOI":"10.1017\/S2045796019000283"},{"key":"2622_CR18","doi-asserted-by":"publisher","unstructured":"Lorenzi CH et al (2022) Aug., Replication of a predictive model for youth ADHD in an independent sample from a developing country, J Child Psychol Psychiatry, https:\/\/doi.org\/10.1111\/jcpp.13682","DOI":"10.1111\/jcpp.13682"},{"key":"2622_CR19","doi-asserted-by":"publisher","unstructured":"Meehan AJ et al (Jun. 2022) Clinical prediction models in psychiatry: a systematic review of two decades of progress and challenges. Mol Psychiatry 27(6):2700\u20132708. https:\/\/doi.org\/10.1038\/s41380-022-01528-4","DOI":"10.1038\/s41380-022-01528-4"},{"key":"2622_CR20","doi-asserted-by":"publisher","unstructured":"Salum GA et al (2015) Mar., High risk cohort study for psychiatric disorders in childhood: rationale, design, methods and preliminary results, Int. J. Methods Psychiatr. Res., vol. 24, no. 1, Art. no. 1, https:\/\/doi.org\/10.1002\/mpr.1459","DOI":"10.1002\/mpr.1459"},{"key":"2622_CR21","doi-asserted-by":"publisher","unstructured":"Aebi M, Kuhn C, Metzke CW, Stringaris A, Goodman R, Steinhausen H-C (Oct. 2012) The use of the development and well-being assessment (DAWBA) in clinical practice: a randomized trial. Eur Child Adolesc Psychiatry 21(10):559\u2013567. https:\/\/doi.org\/10.1007\/s00787-012-0293-6","DOI":"10.1007\/s00787-012-0293-6"},{"key":"2622_CR22","doi-asserted-by":"publisher","unstructured":"Foreman D, Morton S, Ford T (2009) Exploring the clinical utility of the Development And Well-Being Assessment (DAWBA) in the detection of hyperkinetic disorders and associated diagnoses in clinical practice, J. Child Psychol. Psychiatry, vol. 50, no. 4, pp. 460\u2013470, Apr. https:\/\/doi.org\/10.1111\/j.1469-7610.2008.02017.x","DOI":"10.1111\/j.1469-7610.2008.02017.x"},{"key":"2622_CR23","doi-asserted-by":"publisher","unstructured":"Euesden J, Lewis CM, O\u2019Reilly PF (May 2015) PRSice: polygenic risk score software. Bioinformatics 31(9):1466\u20131468. https:\/\/doi.org\/10.1093\/bioinformatics\/btu848","DOI":"10.1093\/bioinformatics\/btu848"},{"key":"2622_CR24","doi-asserted-by":"publisher","unstructured":"Choi SW, O\u2019Reilly PF (2019) PRSice\u20132: Polygenic Risk Score software for biobank-scale data, GigaScience, vol. 8, no. 7, p. giz082, Jul. https:\/\/doi.org\/10.1093\/gigascience\/giz082","DOI":"10.1093\/gigascience\/giz082"},{"key":"2622_CR25","doi-asserted-by":"publisher","unstructured":"Dias-Viana JL, Gomes GVA (Aug. 2019) Escala Wechsler De Intelig\u00eancia para Crian\u00e7as (WISC): an\u00e1lise da produ\u00e7\u00e3o de artigos cient\u00edficos brasileiros. Psicol Rev 28(1):9\u201336. https:\/\/doi.org\/10.23925\/2594-3871.2019v28i1p","DOI":"10.23925\/2594-3871.2019v28i1p"},{"key":"2622_CR26","doi-asserted-by":"publisher","unstructured":"Vandierendonck A, Kemps E, Fastame MC, Szmalec A (Feb. 2004) Working memory components of the Corsi blocks task. Br J Psychol 95(1):57\u201379. https:\/\/doi.org\/10.1348\/000712604322779460","DOI":"10.1348\/000712604322779460"},{"key":"2622_CR27","doi-asserted-by":"publisher","unstructured":"Bexkens A, Ruzzano L, d\u2019 AMLC, Escury-Koenigs MW, Van der Molen, Huizenga HM (Jan. 2014) Inhibition deficits in individuals with intellectual disability: a meta-regression analysis. J Intellect Disabil Res 58(1):3\u201316. https:\/\/doi.org\/10.1111\/jir.12068","DOI":"10.1111\/jir.12068"},{"key":"2622_CR28","doi-asserted-by":"publisher","unstructured":"Toplak ME, Dockstader C, Tannock R (Feb. 2006) Temporal information processing in ADHD: findings to date and new methods. J Neurosci Methods 151(1):15\u201329. https:\/\/doi.org\/10.1016\/j.jneumeth.2005.09.018","DOI":"10.1016\/j.jneumeth.2005.09.018"},{"key":"2622_CR29","doi-asserted-by":"publisher","unstructured":"Martel MM et al (Jan. 2017) A general psychopathology factor (P factor) in children: structural model analysis and external validation through familial risk and child global executive function. J Abnorm Psychol 126(1):137\u2013148. https:\/\/doi.org\/10.1037\/abn0000205","DOI":"10.1037\/abn0000205"},{"key":"2622_CR30","doi-asserted-by":"publisher","unstructured":"Sjoberg D, Whiting DK, Curry M, Lavery J A., and, Larmarange J (2021) Reproducible Summary tables with the Gtsummary Package. R J 13(1):570. https:\/\/doi.org\/10.32614\/RJ-2021-053","DOI":"10.32614\/RJ-2021-053"},{"key":"2622_CR31","doi-asserted-by":"publisher","unstructured":"Rosseel Y (2012) Lavaan: an R Package for Structural equation modeling. J Stat Softw 48(2). https:\/\/doi.org\/10.18637\/jss.v048.i02","DOI":"10.18637\/jss.v048.i02"},{"key":"2622_CR32","doi-asserted-by":"publisher","unstructured":"Pastore M (Dec. 2018) Overlapping: a R package for estimating overlapping in empirical distributions. J Open Source Softw 3(32):1023. https:\/\/doi.org\/10.21105\/joss.01023","DOI":"10.21105\/joss.01023"},{"key":"2622_CR33","doi-asserted-by":"publisher","unstructured":"Bhullar A, Kumar K, Anand A (Jan. 2023) ADHD and neuropsychology: Developmental Perspective, Assessment, and interventions. Ann Neurosci 30(1):5\u20137. https:\/\/doi.org\/10.1177\/09727531231171765","DOI":"10.1177\/09727531231171765"},{"key":"2622_CR34","doi-asserted-by":"crossref","unstructured":"Ungar M, Theron L Resilience and mental health: how multisystemic processes contribute to positive outcomes. Lancet Psychiatry, 7, 5, pp. 441\u2013448, May 2020, doi: 10.1016\/S2215\u20130366(19)30434\u20131.","DOI":"10.1016\/S2215-0366(19)30434-1"},{"key":"2622_CR35","doi-asserted-by":"publisher","unstructured":"Van Rooij D et al (2015) Jul., Distinguishing Adolescents With ADHD From Their Unaffected Siblings and Healthy Comparison Subjects by Neural Activation Patterns During Response Inhibition, Am. J. Psychiatry, vol. 172, no. 7, pp. 674\u2013683, https:\/\/doi.org\/10.1176\/appi.ajp.2014.13121635","DOI":"10.1176\/appi.ajp.2014.13121635"},{"key":"2622_CR36","doi-asserted-by":"publisher","unstructured":"Wackerhagen C et al (2017) Jul., Influence of Familial Risk for Depression on Cortico-Limbic Connectivity During Implicit Emotional Processing, Neuropsychopharmacology, vol. 42, no. 8, pp. 1729\u20131738, https:\/\/doi.org\/10.1038\/npp.2017.59","DOI":"10.1038\/npp.2017.59"},{"key":"2622_CR37","doi-asserted-by":"publisher","unstructured":"Van Sprang ED et al (2022) Mar., Familial risk for depressive and anxiety disorders: associations with genetic, clinical, and psychosocial vulnerabilities, Psychol. Med., vol. 52, no. 4, pp. 696\u2013706, https:\/\/doi.org\/10.1017\/S0033291720002299","DOI":"10.1017\/S0033291720002299"},{"key":"2622_CR38","doi-asserted-by":"publisher","unstructured":"Demro C, Lahud E, Burton PC, Purcell JR, Simon JJ, Sponheim SR (Jan. 2024) Reward anticipation-related neural activation following cued reinforcement in adults with psychotic psychopathology and biological relatives. Psychol Med 1\u201311. https:\/\/doi.org\/10.1017\/S0033291723003343","DOI":"10.1017\/S0033291723003343"},{"key":"2622_CR39","doi-asserted-by":"publisher","unstructured":"Toro VD et al (2024) Feb., The interaction between early life complications and a polygenic risk score for schizophrenia is associated with brain activity during emotion processing in healthy participants, Psychol. Med., pp. 1\u201310, https:\/\/doi.org\/10.1017\/S0033291724000011","DOI":"10.1017\/S0033291724000011"},{"key":"2622_CR40","doi-asserted-by":"publisher","unstructured":"Mooney MA et al (2021) Jun., Smaller total brain volume but not subcortical structure volume related to common genetic risk for ADHD, Psychol. Med., vol. 51, no. 8, pp. 1279\u20131288, https:\/\/doi.org\/10.1017\/S0033291719004148","DOI":"10.1017\/S0033291719004148"},{"key":"2622_CR41","doi-asserted-by":"publisher","unstructured":"Liu B et al (May 2016) Polygenic risk for Schizophrenia influences cortical gyrification in 2 Independent General populations. Schizophr Bull sbw051. https:\/\/doi.org\/10.1093\/schbul\/sbw051","DOI":"10.1093\/schbul\/sbw051"},{"key":"2622_CR42","doi-asserted-by":"publisher","unstructured":"Kotov R et al (May 2017) The hierarchical taxonomy of psychopathology (HiTOP): a dimensional alternative to traditional nosologies. J Abnorm Psychol 126(4):454\u2013477. https:\/\/doi.org\/10.1037\/abn0000258","DOI":"10.1037\/abn0000258"},{"key":"2622_CR43","doi-asserted-by":"publisher","unstructured":"Shaw P et al (Feb. 2011) Cortical development in typically developing children with symptoms of hyperactivity and impulsivity: support for a dimensional view of attention deficit hyperactivity disorder. Am J Psychiatry 168(2):143\u2013151. https:\/\/doi.org\/10.1176\/appi.ajp.2010.10030385","DOI":"10.1176\/appi.ajp.2010.10030385"}],"container-title":["European Child &amp; Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-024-02622-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00787-024-02622-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-024-02622-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T10:16:20Z","timestamp":1754648180000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00787-024-02622-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["2622"],"URL":"https:\/\/doi.org\/10.1007\/s00787-024-02622-4","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"assertion":[{"value":"15 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors assert that all procedures contributing to this study comply with the ethical standards and are approved by the National Research Ethics Commission (Comiss\u00e3o Nacional de \u00c9tica em Pesquisa), the University of S\u00e3o Paulo and the Federal University of Rio Grande do Sul ethics committees. The authors assert that all procedures contributing to this study also comply with the Helsinki Declaration of 1975, as revised in 2008.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical considerations"}},{"value":"Dr. Rohde has received grant or research support from, served as a consultant to, and served on the speakers\u2019 bureau of Abdi Ibrahim, Abbott, Ach\u00e9, Adium, Apsen, Bial, Cellera, EMS, Hypera Pharma, Knight Therapeutics, Libbs, Medice, Novartis\/Sandoz, Pfizer\/Upjohn\/Viatris, Shire\/Takeda, and Torrent in the last three years. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by Dr Rohde have received unrestricted educational and research support from the following pharmaceutical companies in the last three years: Novartis\/Sandoz and Shire\/Takeda. Dr Rohde has received authorship royalties from Oxford Press and ArtMed. Dr. Kieling reported grants from the Centre for Addiction and Mental Health during the conduct of the study; is a Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq, Brazil) researcher and a UK Academy of Medical Sciences Newton Advanced Fellow; and is the founder of Wida. Dr. Caye reported personal fees from Knight Therapeutics outside the submitted work. Hoffmann is supported by the United States National Institutes of Health grant R01MH120482 under his post-doctoral fellowship at UFRGS and by the Wellcome Mental Health Data Prize, granted by the Wellcome Trust (grant number 84494R). Dr. Pan received payment or honoraria for lectures and presentations in educational events for Abbot, Libbs, Instituto Israelita de Pesquisa e Ensino Albert Einstein. He is the co-founder and a substantial shareholder of the MINDCHECK medical company, which develops measurement-based tools for mental health evaluations and clinical care. All other authors report no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}